14Dec
Financial Daily Dose 12.14.2020 | Top Story: AstraZeneca Acquires Alexion in $39 Billion Push into Immunology
Drugmaker AstraZeneca agreed on Saturday to buy biopharma company Alexion for $39 billion in cash and stock. In the deal—the “biggest by a health care company this year”—will help AstraZeneca expand into the immunology sector....
By:
Robins Kaplan LLP
Related
On June 20, the U.S. Departments of Labor, Treasury, and Health and Human Services (the Departments)...
Read More >
In times of uncertainty and disruption, setting expectations for performance with business partners ...
Read More >
Now that the calendar has flipped to 2020, planning and fundraising efforts are intensifying in adva...
Read More >
No employer is immune from the storm of legislation Congress has passed in response to the COVID-19 ...
Read More >
The National Labor Relations Board decided Tuesday, December 17th, that employees have no statutory ...
Read More >
On June 14, 2019, a plurality of the Kansas Supreme Court struck down Kansas’s statutory cap limiti...
Read More >